Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
08/2010
08/10/2010US7772235 4-(5-{(1R)-1-[5-(3-Chlorophenyl)isoxazol-3-yl]ethoxy}-4-methyl-4H-1,2,- 4-triazol-3-yl)-1-methylpyridin-2(1H)-one; transient lower esophageal sphincter relaxations; gastroesophageal reflux disease; pain; anxiety; irritable bowel syndrome; metabotropic glutamate receptor inhibitors; peripherally acting
08/10/2010US7772234 Bicyclic inhibitors of MEK and methods of use thereof
08/10/2010US7772233 Arylamino N-heteroaryl compounds as MEK inhibitors
08/10/2010US7772231 such as cis-4-(4-(4-amino-3-(2-phenyl-1H-benzimidazol-6-yl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)cyclohexyl)-1-methylpiperazin-2-one, used as anticarcinogenic agents
08/10/2010US7772224 Calcitonin gene-related peptide (CGRP) receptor antagonists such as N-[1-(2,3-Difluorobenzyl)-5-oxo-4-(2,22-trifluoroethyl)-1,4-diazepan-6-yl]-4-(2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin-1-yl)piperidine-1-carboxamide, used for treating headaches
08/10/2010US7772221 2-ethyl-hexanoic acid ((1S,4R,5S,8S,14R)-5-benzyl-4-hydroxy-18-methoxy-7-oxo-13-oxa-2,6-diaza-tricyclo[12.6.1.015,20]henicosa-10, 15(20),16,18-tetraen-8-yl)-methyl-amide; Alzheimer's Disease, Down's Syndrome; inhibitors of beta-secretase processing of amyloid precursor proteins
08/10/2010US7772190 E.g., isobutyl N-methyl-N-trimethylallophanoyl-L-alanyl-D-lactate; using parasiticides and nematocides in medicine and veterinary medicine; productive and breeding animals; foods and feeds
08/10/2010CA2559397C Substituted morpholine and thiomorpholine derivatives
08/10/2010CA2483159C Triazole derivatives as tachykinin receptor antagonists
08/10/2010CA2462132C 1,2,4-triazole compounds
08/10/2010CA2451452C Cyclic diamine compound with condensed-ring groups
08/10/2010CA2366800C Carboxylic acid derivatives that inhibit the binding of integrins to their receptors
08/10/2010CA2249542C Pyrazole derivatives, their preparation and their use in pharmaceuticals
08/10/2010CA2237099C Sulfonylaminocarboxylic acids
08/10/2010CA2148140C Homogeneous method for assay of double-stranded nucleic acids using fluorescent dyes and kit useful therein
08/05/2010WO2010087315A1 Anti-alzheimer’s disease agent
08/05/2010WO2010087313A1 Neurite elongation stimulator
08/05/2010WO2010087306A1 Anti-neurodegenerative disease agent
08/05/2010WO2010086403A1 Azetidines as histamine h3 receptor antagonists
08/05/2010WO2010086366A1 4-aryl-butane-1,3-diamides
08/05/2010WO2010086259A1 Piperidine derivatives as nk3 receptor antagonists
08/05/2010WO2010086225A1 Insecticidal compounds
08/05/2010WO2010085968A1 Toluidine sulfonamides and their use as hif-inhibitors
08/05/2010WO2010070068A3 Isoxazoline derivatives and their use as pesticide
08/05/2010WO2010040843A3 Dibenzocycloheptanone derivatives and pharmaceutical agents containing said compounds
08/05/2010WO2010031708A3 Ortho-aminoanilides for the treatment of cancer
08/05/2010WO2009100872A8 Urea derivatives of benzomorphanes and related scaffolds, medicaments containing such compounds and their use
08/05/2010US20100197918 2,4-pyrimidinediamine compounds and their uses
08/05/2010US20100197911 Nitrogen-Containing Aromatic Derivatives
08/05/2010US20100197909 Mutilin derivative having heterocyclic aromatic ring carboxylic acid structure in subtituent at 14-position
08/05/2010US20100197908 Pyridazine Derivatives with MCH Antagonistic Activity and Medicaments Comprising These Compounds
08/05/2010US20100197699 I-OXA-3-Azaspiro (4.5) Decan-2-One And 1-OXA-3, 8-Diazaspiro (4.5) Decan-2-One Derivatives For The Treatment of Eating Disorders
08/05/2010US20100197697 Piperidine derivatives as nk3 receptor antagonists
08/05/2010US20100197690 Pyrimidinyl Pyridazinone Derivatives
08/05/2010US20100197689 Novel processes for the preparation of piperazinyl and diazapanyl benzamide derivatives
08/05/2010US20100197688 Epha4 rtk inhibitors for treatment of neurological and neurodegenerative disorders and cancer
08/05/2010US20100197687 Indoles Useful in the Treatment of Inflammation
08/05/2010US20100197686 Therapeutic compounds
08/05/2010US20100197685 Novel benzofuran type derivatives, a composition comprising the same for treating or preventing cognitive dysfunction and the use thereof
08/05/2010US20100197683 Fused ring compound and use thereof
08/05/2010US20100197674 Oxopyrazine derivative and herbicide
08/05/2010US20100197673 Indole and indazole compounds as an inhibitor of cellular necrosis
08/05/2010US20100197672 Pyrrole compounds as inhibitors of mycobacteria, synthesis thereof and intermediates thereto
08/05/2010US20100197671 Phenyl amino pyrimidine compounds and uses thereof
08/05/2010US20100197667 Biphenyl compounds useful as muscarinic receptor antagonists
08/05/2010US20100197665 Indazole derivatives as kinase inhibitors for the treatment of cancer
08/05/2010US20100197662 Heterocyclic compound having type i 11 beta hydroxysteroid dehydrogenase inhibitory activity
08/05/2010US20100197657 2-aryl or heteroaryl indole derivatives
08/05/2010US20100197654 Triazine kinase inhibitors
08/05/2010US20100197652 Pyridine carboxamide orexin receptor antagonists
08/05/2010US20100197651 Pyridazinone compounds
08/05/2010US20100197645 Thioamide Derivatives as Progesterone Receptor Modulators
08/05/2010US20100197644 Chemical Compounds 572
08/05/2010US20100197640 Novel sulfamoyl-phenyl-ureido compounds and their use as medicament
08/05/2010US20100197634 Inhibitors of janus kinases
08/05/2010US20100197630 Cetp inhibitors derived from benzoxazole arylamides
08/05/2010US20100197564 Diaryl morpholines as cb1 modulators
08/05/2010US20100197502 Crystalline form of [3-(4,5-dihydro-3-isoxazolyl)-2-methyl-4-(methylsulfonyl)phenyl]-(5-hydroxy-1-methyl-1H-pyrazol-4-yl)methanone
08/05/2010US20100196368 Substituted benz-azoles and methods of their use as inhibitors of raf kinase
08/05/2010US20100196357 Microrna modulators and method for identifying and using the same
08/05/2010CA2751285A1 Bicyclic amide derivatives for enhancing glutamatergic synaptic responses
08/05/2010CA2751239A1 Azetidines as histamine h3 receptor antagonists
08/05/2010CA2747961A1 Piperidine derivatives as nk3 receptor antagonists
08/04/2010EP2213661A1 c-Met Modulators and Methods of Use
08/04/2010EP2213660A1 5-substituted indol-3-carboxylic acid derivatives exhibiting antiviral activity a method for the production and use thereof
08/04/2010EP2213290A1 Agent for improving motor complications or psychiatric symptoms in parkinson's disease
08/04/2010EP2212317A1 4,4-disubstituted piperidines
08/04/2010EP2212316A1 Amino 1,2,4-triazole derivatives as modulators of mglur5
08/04/2010EP2212315A1 Trisubstituted piperidines
08/04/2010EP2212314A1 Imidazolidine-2,4-dione (hydantoin) derivatives useful as npy y2 receptor modulators
08/04/2010EP2212304A1 Insecticidal compounds
08/04/2010EP2212303A1 Novel benzamide derivatives useful as potassium channel modulators
08/04/2010EP2212297A1 Inhibitors of protein kinases
08/04/2010EP2212291A1 Heterocycle phenyl amide t-type calcium channel antagonists
08/04/2010EP2212286A1 Synthesis of quaternary salt compounds
08/04/2010EP2212283A1 Substituted n-phenyl-bipyrrolidine carboxamides and therapeutic use thereof
08/04/2010EP2211615A1 Pyridosulfonamide derivatives as pi3 kinase inhibitors
08/04/2010EP2010506B1 Diazepan derivatives modulators of chemokine receptors
08/04/2010EP1638947B1 Triazole derivatives as inhibitors of 11-beta hydroxysteroid dehydrogenase-1
08/04/2010CN1824662B Substituted pyridine herbicides
08/04/2010CN101796049A Process for the production of substituted 5-quinolyl-oxazoles and pharmaceutically acceptable salts thereof
08/04/2010CN101796048A Trisubstituted pyrimidine derivatives for the treatment of proliferative diseases
08/04/2010CN101796038A Oxazole tyrosine kinase inhibitors
08/04/2010CN101796034A Novel 1,2,3-triazole derivatives useful as modulators of nicotinic acetylcholine receptors
08/04/2010CN101796031A Hetero bicyclic carboxamide derivatives and their pharmaceutical use and compositions
08/04/2010CN101792523A Novel polyester chain extender and preparation method thereof
08/04/2010CN101792437A Tolyltriazole derivatives, preparation method thereof and use thereof
08/03/2010US7767821 fluorescent dyes comporising a benzoxadiazole nucleus, suitable for use as components of biosensors for detecting ligands and analytes
08/03/2010US7767818 Hepatitis C inhibitor dipeptide analogs
08/03/2010US7767812 Crystals of pyrimidine compound and process for producing the same
08/03/2010US7767811 Kinetic resolutions of chiral 2- and 3-substituted carboxylic acids
08/03/2010US7767706 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication
08/03/2010US7767702 Combinations of oxazolidinones such as rivaroxaban with a platelet aggregation inhibitor such as a clopidogrel for the prophylaxis and/or treatment of thromboembolic disorders
08/03/2010US7767695 Substituted piperidines
08/03/2010US7767684 N-acylsulfonamide derivatives; BCL-X1 protein inhibitors; anticarcinogenic agents; bladder cancer; for example, N-(4-(4-((4'-chloro(1,1'-biphenyl)-2-yl)methyl)piperazin-1-yl)benzoyl)-4-(((1R)-3-(dimethylamino)-1-((phenylsulfanyl)methyl)-propyl)amino)-3-nitrobenzenesulfonamide
08/03/2010US7767681 chemokine receptor modulators such as N-[4-(2-methoxy-5-propoxyphenyl)thiazol-2-yl]-N'-[4-(2-morpholin-4-ylethyl)piperazin-1-yl]urea, used for the prevention or treatment of asthma, arthritis, allergies, autoimmune diseases, atherosclerosis or angiogenesis
08/03/2010US7767676 2-amino-3,6-dihydro-4-dimethyl-amino-6-ethyl-1,3,5-triazine hydrochloride; advanced glycosylation end-products inhibitor;antidiabetic, insulin resistance, neurodegenerative disorders, renal complications, atherosclerosis, angiopathy
08/03/2010US7767674 Suppression cytokines, tumor necrosis factor
08/03/2010US7767673 N-substituted imidazopyridine c-Kit inhibitors
08/03/2010US7767670 Substituted 3-carboxamido isoxazoles as kinase modulators
1 ... 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 ... 647